|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|
| Operating expenses | ||
| Research and development | ||
| General and administrative | ||
| Total operating expenses | ||
| Operating loss | ||
| Other income | ||
| Income tax provision | ||
| Net loss | ||
| Other comprehensive gain: | ||
| Unrealized gain on marketable securities | ||
| Other comprehensive gain | ||
| Comprehensive loss | ||
| Net loss per ordinary share - basic | ||
| Net loss per ordinary share - diluted | ||
| Weighted average common shares outstanding - basic | ||
| Weighted average common shares outstanding - diluted |
Loading...
